NEW YORK (Reuters Health) – From 1985 to 2007, the initial CD4+ cell counts seen at diagnosis in HIV-infected patients in the US have fallen, suggesting that the…
NEW YORK (Reuters Health) – The results of a new study suggest that tuberculosis may be cured faster by adding moxifloxacin to a standard TB treatment protocol than…
NEW YORK (Reuters Health) – Patients with HIV who are not started on highly activate antiretroviral therapy (HAART) until their CD4+ cell count dips below 200 cells/mm³ may…
NEW YORK (Reuters Health) – In those relatively rare “slow-progressing” HIV-infected patients who mount an effective immune response to the infection, the neutralizing activity is made up of…
NEW YORK (Reuters Health) – A gene therapy protocol developed by scientists in Australia and the US for treatment of HIV-1 infection suppressed viral load and increased CD4…
NEW YORK (Reuters Health) – An ultrasensitive assessment of HIV-RNA levels in HAART-treated patients with subclinical viral loads reveals that nevirapine-based regimens are more effective in this setting…
NEW YORK (Reuters Health) – The results of small study suggests that radiotherapy can be safely used to treat prostate cancer in HIV-infected men, having no long-term effect…
NEW YORK (Reuters Health) – Treatment with a single dose of PRO 140, a monoclonal antibody targeting the CCR5 chemokine receptor, provides potent and prolonged antiviral activity in…
Francis Cordova, MD, Medical Director, Lung Transplantation Program, Temple University School of Medicine, discusses indications for lung transplantation in COPD patients and the use of the BODE index.…
Kathleen Brennan, MD, Director of the Pulmonary Outpatient Clinic at Temple University School of Medicine, discusses the indications for pneumococcal vaccination. References and Resources Deuter, C., et al.…